about
Cross-sectional study of cytomegalovirus shedding and immunological markers among seropositive children and their mothersClinical findings and adverse outcome in neonates with symptomatic congenital cytomegalovirus (SCCMV) infection.Epidemiological survey of human cytomegalovirus antibody levels in children from Southeastern China.Diagnosis of and screening for cytomegalovirus infection in pregnant women.Oral hexadecyloxypropyl-cidofovir therapy in pregnant guinea pigs improves outcome in the congenital model of cytomegalovirus infection.Vaccine-induced control of viral shedding following rhesus cytomegalovirus challenge in rhesus macaques.Open reading frames carried on UL/b' are implicated in shedding and horizontal transmission of rhesus cytomegalovirus in rhesus monkeys.Human cytomegalovirus infection interferes with the maintenance and differentiation of trophoblast progenitor cells of the human placentaGuinea Pig Cytomegalovirus (GPCMV): A Model for the Study of the Prevention and Treatment of Maternal-Fetal Transmission.Translational mini-review series on infectious disease: congenital cytomegalovirus infection: 50 years on.Manipulation of dendritic cell functions by human cytomegalovirus.Rehabilitation and outcome of severe profound deafness in a group of 16 infants affected by congenital cytomegalovirus infection.Human cytomegalovirus UL55, UL144, and US28 genotype distribution in infants infected congenitally or postnatally.Vestibular-evoked myogenic potentials and caloric stimulation in infants with congenital cytomegalovirus infection.Distribution of UL144, US28 and UL55 genotypes in Polish newborns with congenital cytomegalovirus infections.
P2860
Q30599280-FF28BDA0-82DC-43FC-B3C8-E5E75B42DDB2Q31048548-45C22423-81AA-4ED4-BFCC-6F0AAB19BD1BQ33891472-8DFB0231-0684-426A-92C0-55728657D047Q34042125-05FB2594-76B4-4876-A24D-FE8E3B8ECE61Q34483696-433D9CE5-6AAA-44F3-90F3-BFED389008D3Q34742892-00C104FD-9745-40A7-AC48-8A0BC1BF9F6AQ35076699-AAC63B1E-9478-4CB9-AD28-6B10FF24FC0AQ35488673-D6B981D3-DC22-4DCB-930E-B3E7A91C4BFEQ36517126-21723FC9-4181-49B1-B9B4-84442FA1B9BDQ36884194-838E1B8D-1D40-446E-B8E5-1C9408D0F81AQ37331842-090326A3-467D-4991-98C8-A7661CC8CAA5Q37414054-4D93A9EE-7D67-4747-9D17-D959678C1C61Q41272231-27C031D6-C15B-4E94-B677-7525E3BBF281Q50455564-D891FAAA-0E69-43A0-952C-0123087F5EF7Q54341104-E21387BF-D64B-475C-84A0-E707CA8B5376
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Strategies to prevent CMV infection in the neonate.
@ast
Strategies to prevent CMV infection in the neonate.
@en
Strategies to prevent CMV infection in the neonate.
@nl
type
label
Strategies to prevent CMV infection in the neonate.
@ast
Strategies to prevent CMV infection in the neonate.
@en
Strategies to prevent CMV infection in the neonate.
@nl
prefLabel
Strategies to prevent CMV infection in the neonate.
@ast
Strategies to prevent CMV infection in the neonate.
@en
Strategies to prevent CMV infection in the neonate.
@nl
P1476
Strategies to prevent CMV infection in the neonate.
@en
P2093
Paul D Griffiths
P304
P356
10.1016/S1084-2756(02)90123-5
P577
2002-08-01T00:00:00Z